Home/News/Spotify's Daniel Ek to Launch US Body-Scanning Clinics
The Verge2 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

Spotify's Daniel Ek to Launch US Body-Scanning Clinics

Neko Health, the body-scanning startup founded by Spotify CEO Daniel Ek, is expanding to the United States. The company announced this week that it has raised $700 million in funding from a diverse group of investors, including celebrities, entrepreneurs, and investment firms. This significant capital infusion will fuel the launch of Neko Health's first clinic in New York City later this year.

Following its US debut, Neko Health plans a rapid expansion across the country, aiming to make its advanced health assessment services more accessible. The company's core offering involves comprehensive full-body scans designed to detect potential health issues at an early stage. These scans utilize advanced imaging and diagnostic technologies to provide individuals with detailed insights into their health status.

The $700 million funding round saw participation from notable figures and entities, underscoring strong confidence in Neko Health's mission and business model. While specific investor names were not fully disclosed, the mention of "star-studded" individuals and prominent investment firms indicates a broad base of support. This financial backing positions Neko Health to compete effectively in the growing preventative healthcare market.

Neko Health's expansion into the US marks a significant milestone for the Swedish-founded company. Ek's venture aims to democratize access to cutting-edge health diagnostics, moving beyond traditional healthcare check-ups to offer a more proactive and data-driven approach to personal well-being. The establishment of clinics in major US cities is expected to be a key part of this strategy.

Original source — read the full reporting at the publisher:

Read on The Verge

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next